✦ LIBER ✦

Efficacy of low-dose alpha interferon therapy in HBV-related chronic liver disease in Asian Indians: a randomized controlled trial

✍ Scribed by Shiv K. Sarin; R.C. Guptan; Varsha Thakur; Shailaja Malhotra; Veena Malhotra; Kakoli Banerjee; Pramod Khandekar

Book ID: 118567346
Publisher: Elsevier Science
Year: 1996
Tongue: English
Weight: 588 KB
Volume: 24
Category: Article
ISSN: 0168-8278
DOI: 10.1016/s0168-8278(96)80158-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Prevention of relapse in patients with c

Prevention of relapse in patients with chronic non-A, non-B/C hepatitis who respond to alpha-interferon. A controlled multicenter trial of low-dose maintenance therapy

✍ Dominique Valla; Gérard Babany; Denis Ouzan; Christian Trépo; Marc Bourlière; Pa 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 384 KB

Efficacy and safety of high-dose pravast

Efficacy and safety of high-dose pravastatin in hypercholesterolemic patients with well-compensated chronic liver disease: Results of a prospective, randomized, double-blind, placebo-controlled, multicenter trial

✍ James H. Lewis; Mary Ellen Mortensen; Steven Zweig; Mary Jean Fusco; Jeffrey R. 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 148 KB 👁 2 views

The hepatotoxic potential of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors in patients with underlying chronic liver disease remains controversial. We performed a multicenter, randomized, double-blind, placebo-controlled, parallel-group trial that compared pravastatin (80 mg) to a place

Influence of low iron diet on the effica

Influence of low iron diet on the efficacy of interferon therapy in patients with HBV related chronic liver disease: R C Guptan, S K Sarin, S Malhotra, K Banerjee, P Khandekar. Dept. of Gastroenterology, G.B.Pant Hospital, NII, Delhi

📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 134 KB